SymBiosis Capital Partners’s Generation Bio GBIO Stock Holding History

SymBiosis Capital Partners’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-665,000	Closed	-$3.78M	–	8
2025 Q4	$3.78M	Buy	+665,000	New	+$3.76M	3.45%	10

Other funds holding GBIO

ACM

Accent Capital Management Centerville, Ohio $231M AUM 33.86% 1-Year Est. Return

SymBiosis Capital Partners's GBIO Position: Q1 2026 in Review

SymBiosis Capital Partners sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 665,000 shares — an estimated $3.78M sold.

SymBiosis Capital Partners first reported a position in GBIO in Q4 2025 and held it in 1 quarter. The position peaked at $3.78M in Q4 2025. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

SymBiosis Capital Partners reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
SymBiosis Capital Partners sold 665,000 Generation Bio shares in Q1 2026, an estimated $3.78M.
SymBiosis Capital Partners first reported a position in Generation Bio in Q4 2025 and held it in 1 quarter.
SymBiosis Capital Partners's Generation Bio position peaked at $3.78M in Q4 2025.
2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on SymBiosis Capital Partners's 13F filing for Q1 2026, filed 12 May 2026.